News related to Isentress (Raltegravir) and/or conditions it is approved for
Raltegravir Not Better Than NRTIs for Refractory HIV
Source: Medscape HIV/AIDS Headlines [2014.07.23]
Raltegravir showed no benefits over nucleoside reverse-transcriptase inhibitors when used in combination with a protease inhibitor as second-line HIV therapy.
Medscape Medical News
Baby "Cured" of HIV Infection
Source: MedicineNet nevirapine Specialty [2013.04.03]
Title: Baby "Cured" of HIV Infection
Category: Doctor's & Expert's views on Symptoms
Created: 4/3/2013 6:12:00 PM
Last Editorial Review: 4/3/2013 6:12:53 PM
Real-Life PrEP Works as Hoped
Source: MedPage Today OB/Gyn [2014.07.23]
(MedPage Today) -- MELBOURNE, Australia -- Despite dire warnings, the real-world experience of a daily pill to prevent HIV infection has been that it's both safe and effective, a researcher reported.